Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells
Abstract: Purpose
Mesenchymal stromal cells (MSCs) within the glioblastoma microenvironment have been shown to promote tumor progression. Tumor Treating Fields (TTFields) are alternating electric fields with low intensity and intermediate frequency that exhibit anti-tumorigenic effects. While the effects of TTFields on glioblastoma cells have been studied previously, nothing is known about the influence of TTFields on MSCs.
Methods
Single-cell RNA sequencing and immunofluorescence staining were employed to identify glioblastoma-associated MSCs in patient samples. Proliferation and clonogenic survival of human bone marrow-derived MSCs were assessed after TTFields in vitro. MSC’ characteristic surface marker expression was determined using flow cytometry, while multi-lineage differentiation potential was examined with immunohistochemistry. Apoptosis was quantified based on caspase-3 and annexin-V/7-AAD levels in flow cytometry, and senescence was assessed with ß-galactosidase staining. MSCs’ migratory potential was evaluated with Boyden chamber assays.
Results
Single-cell RNA sequencing and immunofluorescence showed the presence of glioblastoma-associated MSCs in patient samples. TTFields significantly reduced proliferation and clonogenic survival of human bone marrow-derived MSCs by up to 60% and 90%, respectively. While the characteristic surface marker expression and differentiation capacity were intact after TTFields, treatment resulted in increased apoptosis and senescence. Furthermore, TTFields significantly reduced MSCs’ migratory capacity.
Conclusion
We could demonstrate the presence of tumor-associated MSCs in glioblastoma patients, providing a rationale to study the impact of TTFields on MSCs. TTFields considerably increase apoptosis and senescence in MSCs, resulting in impaired survival and migration. The results provide a basis for further analyses on the role of MSCs in glioblastoma patients receiving TTFields
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Journal of neuro-oncology. - 169, 2 (2024) , 329-340, ISSN: 1573-7373
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- Urheber
-
Strack, Maren
Kueckelhaus, Jan
Diebold, Martin
Wuchter, Patrick
Huber, Peter E.
Schnell, Oliver
Sankowski, Roman
Prinz, Marco
Grosu, Anca-Ligia
Heiland, Dieter Henrik
Nicolay, Nils
Rühle, Alexander
- DOI
-
10.1007/s11060-024-04740-0
- URN
-
urn:nbn:de:bsz:25-freidok-2516296
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Strack, Maren
- Kueckelhaus, Jan
- Diebold, Martin
- Wuchter, Patrick
- Huber, Peter E.
- Schnell, Oliver
- Sankowski, Roman
- Prinz, Marco
- Grosu, Anca-Ligia
- Heiland, Dieter Henrik
- Nicolay, Nils
- Rühle, Alexander
- Universität
Entstanden
- 2024
Ähnliche Objekte (12)

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
